The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study to investigate the efficacy and safety of acoustic cluster therapy with modified FOLFIRINOX in patients with locally advanced pancreatic cancer.
 
Erin Pierce
Consulting or Advisory Role - Exelixis; Johnson & Johnson/Janssen; Merck; Pfizer
Speakers' Bureau - Astellas Oncology; Eisai; Exelixis; Johnson & Johnson/Janssen; Merck; Pfizer; Sanofi
 
Matthew Siegel
No Relationships to Disclose
 
Katie Morgan
No Relationships to Disclose
 
S. Danielle Legrand
No Relationships to Disclose
 
Ragnar Bendiksen
Employment - EXACT Therapeutics
Stock and Other Ownership Interests - EXACT Therapeutics; Medistim
 
Nicola Little
Consulting or Advisory Role - Exact Therapeutics
 
Amir Snapir
Employment - Exact Therapeutics
Leadership - Exact Therapeutics
Stock and Other Ownership Interests - Exact Therapeutics
 
Erkut Borazanci
Consulting or Advisory Role - Arcus Biosciences; Corcept Therapeutics; Merus; Revolution Medicines; VCN Biosciences
Research Funding - BioNTech (Inst); Biosplice (Inst); Bristol-Myers Squibb (Inst); Corcept Therapeutics (Inst); Daiichi Sankyo (Inst); Helix BioPharma (Inst); Idera (Inst); Lilly (Inst); Merck (Inst); Minneamrita Therapeutics (Inst); Pharmacyclics (Inst)